Published in Aliment Pharmacol Ther on October 01, 2007
Markers of renal function tests. N Am J Med Sci (2010) 1.35
Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci (2012) 1.12
Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol (2010) 1.05
Renal dysfunction in chronic liver disease. Crit Care (2010) 1.03
Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis. World J Gastroenterol (2009) 0.91
The evolution in the prioritization for liver transplantation. Ann Gastroenterol (2012) 0.87
Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels. Korean J Hepatol (2011) 0.87
Risk factors for acute kidney injury following orthotopic liver transplantation: the impact of changes in renal function while patients await transplantation. BMC Nephrol (2010) 0.84
Difference between CKD-EPI and MDRD equations in calculating glomerular filtration rate in patients with cirrhosis. World J Gastroenterol (2011) 0.82
Urinary biomarkers of acute kidney injury in patients with liver cirrhosis. ISRN Nephrol (2014) 0.81
Renal dysfunction in patients with cirrhosis: Where do we stand? World J Gastrointest Pharmacol Ther (2014) 0.80
Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure. World J Gastroenterol (2013) 0.79
Is There any Difference Between the Glomerular Filtration Rate of Patients With Chronic Hepatitis B and C and Patients With Cirrhosis? Hepat Mon (2013) 0.79
Neutrophil Gelatinase-Associated Lipocalin: A New Marker of Renal Function in C-Related End Stage Liver Disease. Gastroenterol Res Pract (2015) 0.78
Evaluation of renal function in patients with cirrhosis: where are we now? World J Gastroenterol (2014) 0.78
Is an estimated glomerular filtration rate better than creatinine to be incorporated into the end-stage liver disease score? World J Hepatol (2012) 0.77
The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosis. BMC Nephrol (2015) 0.77
Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure. PLoS One (2015) 0.77
Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis. Int J Hepatol (2015) 0.77
Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT. Kidney Res Clin Pract (2012) 0.77
Retracted Urinary biomarkers of acute kidney injury in patients with liver cirrhosis. Med Arch (2014) 0.76
Kidney Failure and Liver Allocation: Current Practices and Potential Improvements. Adv Chronic Kidney Dis (2015) 0.76
The 24 hour urine creatinine clearance for prediction of glomerular filtration rate in liver cirrhosis patients: have we considered all elements? Hepat Mon (2013) 0.76
Plasma Levels of Uric Acid, Urea and Creatinine in Diabetics Who Visit the Clinical Analysis Laboratory (CAn-Lab) at Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. J Clin Diagn Res (2015) 0.75
Effect of psoas muscle mass after endoscopic therapy for patients with esophageal varices. Medicine (Baltimore) (2017) 0.75
Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis. Medicine (Baltimore) (2017) 0.75
Cockcroft-Gault revisited: New de-liver-ance on recommendations for use in cirrhosis. World J Hepatol (2017) 0.75
Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome. Gastroenterol Rep (Oxf) (2017) 0.75
Studies on the cleavage of bacteriophage lambda DNA with EcoRI Restriction endonuclease. J Mol Biol (1975) 19.67
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
Rapid DNA isolations for enzymatic and hybridization analysis. Methods Enzymol (1980) 11.28
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Viable molecular hybrids of bacteriophage lambda and eukaryotic DNA. Proc Natl Acad Sci U S A (1974) 8.97
Functional selection and analysis of yeast centromeric DNA. Cell (1985) 7.74
Tracing European founder lineages in the Near Eastern mtDNA pool. Am J Hum Genet (2000) 7.06
Hybridization of RNA to double-stranded DNA: formation of R-loops. Proc Natl Acad Sci U S A (1976) 6.30
Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature (1998) 6.16
Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol (1983) 5.07
Unique arrangement of coding sequences for 5 S, 5.8 S, 18 S and 25 S ribosomal RNA in Saccharomyces cerevisiae as determined by R-loop and hybridization analysis. J Mol Biol (1978) 5.02
Eukaryotic DNA segments capable of autonomous replication in yeast. Proc Natl Acad Sci U S A (1980) 4.73
Carcinoid tumour. Lancet (1998) 4.52
Health of the Nation Outcome Scales (HoNOS). Research and development. Br J Psychiatry (1998) 4.27
A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer (1981) 4.25
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther (2014) 3.98
The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings. Br J Psychiatry (1993) 3.95
Are epilepsy classifications based on epileptic syndromes and seizure types outdated? Epileptic Disord (2006) 3.36
Increased thrombotic vascular events after change of statin. Lancet (1998) 3.34
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med (1982) 3.16
Vitamin D concentrations in Asian children aged 2 years living in England: population survey. BMJ (1999) 3.14
Control of whooping cough in New Zealand; slow progress. N Z Med J (1995) 3.10
The Brussels Declaration: the need for change in asthma management. Eur Respir J (2008) 2.91
Prospective study of the impact of fear of falling on activities of daily living, SF-36 scores, and nursing home admission. J Gerontol A Biol Sci Med Sci (2000) 2.89
Analysis of 150 patients with acute myocardial infarction admitted to an intensive care and study unit. Br Med J (1968) 2.88
Bihemispheric brain stimulation facilitates motor recovery in chronic stroke patients. Neurology (2010) 2.86
Early results with the Lichtenstein tension-free hernia repair. Br J Surg (1994) 2.77
Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev (2007) 2.75
Home visits by an occupational therapist for assessment and modification of environmental hazards: a randomized trial of falls prevention. J Am Geriatr Soc (1999) 2.74
Investigation of the effects of coffee on alertness and performance during the day and night. Neuropsychobiology (1993) 2.62
Quality of care in private sector and NHS facilities for people with dementia: cross sectional survey. BMJ (2001) 2.59
Zein storage protein gene family of maize. An assessment of heterogeneity with cloned messenger RNA sequences. J Mol Biol (1982) 2.54
Differences in sexual risk behaviour between young men and women travelling abroad from the UK. Lancet (1998) 2.52
Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol (2010) 2.50
Haemodynamic effects of morphine in patients with acute myocardial infarction. Br Heart J (1965) 2.49
Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J (1995) 2.39
Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms. Br J Dermatol (2013) 2.38
Bacterial infection in the pathogenesis of variceal bleeding. Lancet (1999) 2.35
Biological control of locusts and grasshoppers. Annu Rev Entomol (2001) 2.34
Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis. Kidney Int (2008) 2.30
The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant (2012) 2.29
Spina bifida--and the parents. Dev Med Child Neurol (1971) 2.28
Coagulation and fibrosis in chronic liver disease. Gut (2008) 2.22
An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy (2006) 2.22
Physiological validation of the concept of glycemic load in lean young adults. J Nutr (2003) 2.20
Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene (2000) 2.20
Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM (2007) 2.14
Natural history and clinical significance of arrhythmias after acute cardiac infarction. Br Heart J (1967) 2.13
Systematic review and meta-analysis of intraoperative versus preoperative endoscopic sphincterotomy in patients with gallbladder and suspected common bile duct stones. Br J Surg (2011) 2.13
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10
Wegener's granulomatosis: observations on 18 patients with severe renal disease. Q J Med (1983) 2.07
Effects of a pharmacist's medication review in nursing homes. Randomised controlled trial. Br J Psychiatry (2000) 2.06
Urinary excretion of free noradrenaline and adrenaline following acute myocardial infarction. Lancet (1967) 2.04
Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J Sci Am (1998) 2.03
Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev (2000) 2.01
High speed laceration. Br Dent J (2008) 2.01
Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther (2006) 2.00
Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction. Am J Cardiol (1967) 1.98
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet (1999) 1.98
The impact of the symptoms of dementia on caregivers. Br J Psychiatry (1997) 1.96
"Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology (1998) 1.95
Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut (2005) 1.93
Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol (2002) 1.92
Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment. J Cancer Res Clin Oncol (1997) 1.91
A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology (2002) 1.90
Free noradrenaline and adrenaline excretion in relation to the development of cardiac arrhythmias and heart-failure in patients with acute myocardial infarction. Lancet (1969) 1.88
Study of antidiarrhoeal activity of four medicinal plants in castor-oil induced diarrhoea. J Ethnopharmacol (2001) 1.87
An appraisal of the histopathological assessment of liver fibrosis. Gut (2006) 1.87
Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther (2005) 1.86
Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. N Engl J Med (2001) 1.84
Tenofovir-associated renal and bone toxicity. HIV Med (2009) 1.82
Effectiveness of cognitive-behavioural family intervention in reducing the burden of care in carers of patients with Alzheimer's disease. Br J Psychiatry (2000) 1.81
Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol (2013) 1.79
Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases. Lancet (1994) 1.78
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet (1996) 1.78
A G/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis. Circ Res (2004) 1.76
Heterospecific transformation in the genus Haemophilus. Mol Gen Genet (1984) 1.76
A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol (1999) 1.76
Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet (2000) 1.75
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med (1992) 1.72
Circulatory changes associated with systemic hypotension in patients with acute myocardial infarction. Br Heart J (1966) 1.72
Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis. Lancet (1977) 1.71
Iron status of Asian children aged 2 years living in England. Arch Dis Child (1998) 1.70
Hospital outbreak of clostridium perfringens food-poisoning. Lancet (1977) 1.68
Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial. Cancer J Sci Am (1999) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care. J Antimicrob Chemother (2006) 1.64
Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut (1998) 1.63
CD45 regulates Src family member kinase activity associated with macrophage integrin-mediated adhesion. Curr Biol (1997) 1.63